Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

328 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Switching treatments in haemophilia: is there a risk of inhibitor development?
Santagostino E, Auerswald G, Benson G, Dolan G, Jiménez-Yuste V, Lambert T, Ljung R, Morfini M, Remor E, Zupančić Šalek S. Santagostino E, et al. Eur J Haematol. 2015 Apr;94(4):284-9. doi: 10.1111/ejh.12433. Epub 2014 Sep 17. Eur J Haematol. 2015. PMID: 25135593 Free PMC article. Review.
Rationale for individualizing haemophilia care.
Sørensen B, Auerswald G, Benson G, Elezović I, Felder M, Lambert T, Morfini M, Remor E, Salaj P, Santagostino E, Šalek SZ, Ljung R. Sørensen B, et al. Among authors: santagostino e. Blood Coagul Fibrinolysis. 2015 Dec;26(8):849-57. doi: 10.1097/MBC.0000000000000225. Blood Coagul Fibrinolysis. 2015. PMID: 25396764 Review.
Practical aspects of extended half-life products for the treatment of haemophilia.
Lambert T, Benson G, Dolan G, Hermans C, Jiménez-Yuste V, Ljung R, Morfini M, Zupančić-Šalek S, Santagostino E. Lambert T, et al. Among authors: santagostino e. Ther Adv Hematol. 2018 Sep 6;9(9):295-308. doi: 10.1177/2040620718796429. eCollection 2018 Sep. Ther Adv Hematol. 2018. PMID: 30210757 Free PMC article. Review.
Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial.
Lentz SR, Janic D, Kavakli K, Miljic P, Oldenburg J, C Ozelo M, Santagostino E, Suzuki T, Zupancic Šalek S, Korsholm L, Matytsina I, Tiede A. Lentz SR, et al. Among authors: santagostino e. Haemophilia. 2018 Nov;24(6):e391-e394. doi: 10.1111/hae.13617. Epub 2018 Nov 6. Haemophilia. 2018. PMID: 30402994 Clinical Trial.
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies.
Volkers P, Hanschmann KM, Calvez T, Chambost H, Collins PW, Demiguel V, Hart DP, Hay CRM, Goudemand J, Ljung R, Palmer BP, Santagostino E, van Hardeveld EM, van den Berg M, Keller-Stanislawski B. Volkers P, et al. Among authors: santagostino e. Haemophilia. 2019 May;25(3):398-407. doi: 10.1111/hae.13747. Epub 2019 May 7. Haemophilia. 2019. PMID: 31066174 Review.
328 results